Form 4 for HCA HCA Healthcare
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-16 · accession 0001209191-24-003743 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-21 | 2024-02-16 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | A - Grant | $0.00 | +17.0K | 41.9K | +68% | $0 |
| 2024-02-21 | 2024-02-16 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | F - Tax | $308.55 | -6,212 | 35.7K | -15% | -$1.92M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | A | A | 12,560 | $0.00 | 37,488.97 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-16 | F | D | 6,212 | $308.55 | 35,696.97 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-16 | A | A | 4,420 | $0.00 | 41,908.97 | D | — | — |